Modern Slavery and Human Trafficking Statement for financial year 2025 - 2026
- Edward Goredema
- Jun 2
- 2 min read
Introduction
This statement is made pursuant to section 54 of the Modern Slavery Act 2015 and
constitutes The Warren Neurodiversity Service’s modern slavery and human trafficking
statement for the financial year 2025–2026. Although The Warren Neurodiversity Service
does not meet the statutory threshold of £36 million annual turnover, we recognise our
ethical responsibility to uphold the principles of transparency and due diligence in our
operations and supply chains. We are therefore voluntarily publishing this statement in
alignment with NHS contractual obligations and best practice standards.
1. Organisation Structure and Services
The Warren Neurodiversity Service is an independent healthcare provider based in the
United Kingdom. We offer specialist assessment, diagnosis, and treatment services for
Autism Spectrum Conditions and Attention Deficit Hyperactivity Disorder (ADHD) in both
children and adults. Our services are delivered through NHS-commissioned frameworks,
including Right to Choose, and through direct private referral routes.
We employ a multidisciplinary team comprising clinical psychologists, psychiatrists,
specialist nurses, and administrative personnel. Our operations are entirely UK-based.
2. Commitment to Preventing Modern Slavery
The Warren Neurodiversity Service is committed to ensuring that modern slavery, human
trafficking, servitude, and forced or compulsory labour have no place within our
organisation or supply chains. We operate in line with NHS Standard Contract requirements
and ensure that our safeguarding policies reflect national legislation and guidance,
including the Care Act 2014 and Working Together to Safeguard Children.
3. Supply Chains
Our supply chains are limited in scope and primarily relate to clinical systems, IT
equipment, administrative software, medical consumables, and occasional outsourced
professional services (e.g., IT, legal, accounting). All suppliers are UK-based and are
required to demonstrate ethical compliance through procurement checks aligned with NHS
England and Crown Commercial Service standards.
4. Due Diligence and Supplier Assurance
We undertake proportionate due diligence on suppliers prior to engagement and at regular
intervals thereafter. This includes reviewing suppliers’ Modern Slavery Act statements
(where applicable), ensuring appropriate safeguarding and whistleblowing policies are in
place, and requiring confirmation of compliance with UK employment law and ethical
standards. Suppliers involved in patient care or sensitive data handling are subject to
enhanced vetting.
5. Risk Assessment and Mitigation
Given the nature of our services and the location of our supply chain, we assess our overall
risk of exposure to modern slavery as low. Nevertheless, we remain vigilant, particularly in
relation to temporary staffing, facilities management, and any high-risk outsourced
services. Any concerns regarding unethical practice are escalated to senior management
and, where appropriate, reported in accordance with safeguarding and whistleblowing
procedures.
6. Training and Staff Awareness
Safeguarding and whistleblowing training is mandatory for all employees and includes
awareness of modern slavery and human trafficking indicators. Staff are trained to
recognise the signs of exploitation and understand how to report concerns both internally
and through external statutory channels, including the Modern Slavery Helpline and local
safeguarding partnerships.
7. Governance and Review
This statement has been approved by the Directors of The Warren Neurodiversity Service
and is subject to annual review or earlier revision in line with changes in legislation or
identified risk. Compliance with this statement is monitored through our internal
governance framework.
Approved by:
Edward Goredema
Operations Director
The Warren Neurodiversity Service
Date: 26 May 2025
